This month, the Big Ten Cancer Research Consortium highlights our member, the University of Illinois Cancer Center at the University of Illinois at Chicago. In this member feature, we shine the spotlight on two University of Illinois at Chicago investigators who are actively involved in consortium studies and working groups: Irum Khan, MD, and Kent Hoskins, MD.
Residency, Internal Medicine, University of Cincinnati, Ohio
Fellowship, Hematology/Oncology, Northwestern University, Chicago
MS, Clinical and Translational Science, University of Illinois Chicago
Research and Clinical Interests Irum Khan, MD, is as comfortable in a laboratory as she is a hospital. As a clinician, Dr. Khan cares for patients with acute and chronic myeloid malignancies, including leukemia, myeloproliferative and myelodysplastic disorders. Her research is focused on translational studies in myeloid malignancies, identifying therapeutic targets in myeloid leukemia and serving as principal investigator on numerous clinical trials. Read More
March 3, 2021: Big Ten basketball teams battle it out on the hardwood each March in hopes of making it to the madness that’s the national tournament, but this year the institutions are setting aside their rivalries to team up for Screening Madness. Colorectal Cancer Awareness Month tips off each March, and the Big Ten Cancer Research Consortium and The Blue Hat Foundation, a Chicago-based colorectal cancer organization founded by colorectal cancer survivor Candace Henley, are uniting to raise awareness of the disease with a goal of increasing screenings. Colorectal cancer starts in the colon or the rectum, and nearly always develops from precancerous polyps, or... Read More
February 17, 2021: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights current research, appointments, publications, general news, and expansions across member campuses. Read More
February 15, 2021: Researchers leading a Big Ten Cancer Research Consortium phase Ib/II study of concurrent durvalumab and radiation therapy (DUART) in adults with unresectable, cisplatin ineligible locally advanced bladder cancer, reported promising results during recent virtual scientific meetings. Monika Joshi, MD, MRCP, sponsor-investigator of the BTCRC-GU15-023 study, presented a rapid abstract session during the 2021 Genitourinary Cancers Symposium on Friday, Feb. 12, that built upon data previously reported by study co-author Leonard C. Tuanquin, MD, during an oral scientific session at the ASTRO Annual Meeting, on Sunday, Oct. 25, 2020. Read More
February 3, 2021: This month, the Big Ten Cancer Research Consortium highlights the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as our featured member. Daniela Matei, MD, the Diana, Princess of Wales Professor of Cancer Research, professor of Hematology / Oncology and Gynecologic Oncology at Northwestern University Feinberg School of Medicine, and co-leader of the Translational Bridge Program at the Lurie Cancer Center, was featured in the story, “From Behind the Iron Curtain to a Career in Gynecologic Cancer Research,” in the ASCO Post. Read More
February 1, 2021: The Big Ten Cancer Research Consortium recently appointed Elisavet Paplomata, MD, assistant professor of hematology/oncology at University of Wisconsin School of Medicine, and Eugenia Girda, MD, FACOG, assistant professor of obstetrics, gynecology, and reproductive sciences at Rutgers Robert Wood Johnson Medical School, as new co-chairs of the Big Ten CRC’s Gynecologic Clinical Trial Working Group. Their leadership will support collaboration and mentoring opportunities within the working group, and will guide the development of Big Ten CRC gynecologic clinical trials, from initial LOI submission, review, and approval, to expert feedback throughout the life of each ongoing study, and final publication. Read More
January 24, 2021: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights emerging research, new appointments and initiatives that support advancement in the health and treatment of those with cancer. Read More
January 8, 2021: Monika Joshi, MD, MRCP, associate professor of medicine at Penn State College of Medicine and a medical oncologist at Penn State Cancer Institute, has been appointed as the chief scientific officer of the Big Ten Cancer Research Consortium. She succeeds Ruth O’Regan, MD, who now serves as chair of the Department of Medicine at the University of Rochester. The Big Ten CRC announced Dr. Joshi’s appointment during the consortium’s Virtual Summit on January 8. She will serve a three-year, renewable term in her new role. “I’m excited and very honored to be appointed as the CSO for the prestigious Big Ten Cancer Research Consortium,” Dr. Joshi said. “I want to... Read More
January 8, 2021: The Big Ten Cancer Research Consortium (Big Ten CRC) honored Indiana University and Patrick J. Loehrer, Sr., MD, director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, with two new awards during the Big Ten CRC Virtual Summit, hosted by the Cancer Center at Illinois, on Friday, January 8. The Big Ten Cancer Research Consortium Institutional Leadership Award is a new award that will be presented annually to the member institution that provides the greatest overall contribution to the success of the Big Ten CRC. The award is given to the institution that led all member institutions in combined Clinical Trial Working Group participation and patient enrollment on Big... Read More
December 28, 2020: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights recently published research, grants, professional appointments, oral presentations, and developments in basic scientific research across Big Ten cancer centers and universities. Stay current on what’s happening within our Big Ten universities. Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube